Neoadjuvant Nab-Paclitaxel Plus Oxaliplatin, S-1, and Sintilimab in Early-Onset Resectable Gastric Cancer

NCT07018063 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Gastric (Cardia, Body) Cancer
Stomach Adenocarcinoma
Locally Advanced

Interventions

DRUG: nab-paclitaxel
DRUG: oxaliplatin
DRUG: S-1
DRUG: sintilimab
PROCEDURE: D2 Gastrectomy

Sponsor

zhoujing